The pregnancy-associated α2-glycoprotein (α2-PAG) A tumour marker? |
| |
Authors: | H. W. Bauer |
| |
Affiliation: | (1) Urologische Klinik und Poliklinik der Universität München, Klinikum Großhadern, Germany |
| |
Abstract: | Summary Long-term studies of 2-PAG in sera of patients with breast cancer, bronchial carcinoma, gynaecological carcinoma, melanoma and laryngeal carcinoma have proved that 2-PAG is a possible laboratory parameter for the assessment of recurrence of tumour and metastasis. The results published for trophoblastic tumour and gastrointestinal carcinoma are still divergent. Because of the large individual range of 2-PAG concentrations and the widely differing 2-PAG levels in men and women single determinations of this protein are without value. A detailed classification of the pathological mechanisms to which these proteins are submitted is still missing and consequently we have no fundamental knowledge of diseases that apart from pregnancy and neoplasia lead to changes in the physiological 2-PAG serum concentration.Dedicated to Prof. Dr. E. Schmiedt to his 60th birthday (20th of November 1980) |
| |
Keywords: | Pregnancy-associated /content/w44t54443u4878w7/xxlarge945.gif" alt=" agr" align=" BASELINE" BORDER=" 0" >2-glycoprotein Pregnancy Malignant tumours Seroscreening Monitoring of tumour therapy |
本文献已被 SpringerLink 等数据库收录! |